| 1Dehydronorketamine |
|---|
| 2Norketamine |
| 3Ketamine |
| 4Methoxetamine |
| 53-MeO-PCE |
| 63-MeO-PCP |
search
Applications
Identification and Quantification of Designer Drugs in Urine by LC-MS/MS
25865
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Anesthetics,Analgesics,Excitatory Amino Acid Antagonists
Forensics/Toxicology
Toxicology / Drug Screening / TDM
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25865)
Column: |
Brand Name: Kinetex |
Part No: |
Phase Name: C18 |
System: Sciex Applied Biosystems Q TRAP, Mass Analyzer: QQQ-LT, Interface(s): ES/APCI, PI |
Sample Note: To 20 µL urine, add 50 µL internal standard (D5-PCP in acetonitrile). Vortex then centrifuge for 10 min at 15,000 rpm.
Dilute supernatant with 930 µL Mobile Phase A. Mix and transfer to an autosampler vial for injection. |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.